Cargando…
The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells
Hepatitis B X-interacting protein (HBXIP) is an important oncoprotein that plays critical role in the development of cancer. In this study, we report that HBXIP activates LIM-only protein 4 (LMO4), a transcriptional coregulatory protein, in promotion of cell proliferation. We observed that the messe...
Autores principales: | Yue, Lin, Li, Leilei, Liu, Fangfang, Hu, Nan, Zhang, Weiying, Bai, Xiao, Li, Yinghui, Zhang, Yingyi, Fu, Li, Zhang, Xiaodong, Ye, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616668/ https://www.ncbi.nlm.nih.gov/pubmed/23291272 http://dx.doi.org/10.1093/carcin/bgs399 |
Ejemplares similares
-
The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer
por: Liu, Fabao, et al.
Publicado: (2015) -
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
por: Liu, Bowen, et al.
Publicado: (2018) -
The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression
por: Zheng, Sen, et al.
Publicado: (2019) -
Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
por: Zhang, Jun, et al.
Publicado: (2021) -
HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis
por: Zhang, Lu, et al.
Publicado: (2023)